What is it about?
Treatment options for NON squamous NSCLC patients without actionable biomarkers
Featured Image
Why is it important?
They are still the most important population in everyday practice
Perspectives
This is an opportunity to reflect about this kind of patients, which probably soffer of a lack of dedicated clinical trials.
Alessio Cortellini
Medical Oncology, St. Salvatore Hospital, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy
Read the Original
This page is a summary of: Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice, Thoracic Cancer, December 2017, Wiley,
DOI: 10.1111/1759-7714.12570.
You can read the full text:
Contributors
The following have contributed to this page
